PTCH1 gene polymorphisms in ovarian tumors: potential protective role of c.3944T allele

Gene. 2013 Mar 15;517(1):55-9. doi: 10.1016/j.gene.2012.12.089. Epub 2013 Jan 9.

Abstract

In this study we investigated the types and role of different genetic changes of PTCH1 gene in three different types of ovarian tumors: carcinomas, fibromas and dermoids. LOH of the PTCH1 region was detected in 27.3% ovarian carcinoma samples, 18.18% ovarian fibroma samples and 55.56% ovarian dermoid samples. No point mutations were detected in any of the three types of ovarian tumors. SNP c.3944C>T showed significant differences between ovarian carcinoma and control samples with the minor T allele being significantly higher in controls compared to ovarian carcinomas. Interestingly, a new polymorphism c.-1184G>A was found only in tumor samples and further analyses should be performed in order to elucidate its potential role in ovarian tumors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles
  • Case-Control Studies
  • Dermoid Cyst / blood
  • Dermoid Cyst / genetics*
  • Dermoid Cyst / pathology
  • Female
  • Fibroma / blood
  • Fibroma / genetics*
  • Fibroma / pathology
  • Humans
  • Loss of Heterozygosity
  • Neoplasm Staging
  • Ovarian Neoplasms / blood
  • Ovarian Neoplasms / genetics*
  • Ovarian Neoplasms / pathology
  • Patched Receptors
  • Patched-1 Receptor
  • Point Mutation / genetics*
  • Polymorphism, Genetic / genetics*
  • Prognosis
  • Receptors, Cell Surface / genetics*

Substances

  • PTCH1 protein, human
  • Patched Receptors
  • Patched-1 Receptor
  • Receptors, Cell Surface